Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-15, Stock:ABBV, The news for the past five days is as follows:
2018-05-08: NEWS1: Keytruda: Merck’s Immuno-Oncology Blockbuster Drug in 1Q18.NEWS2: Celgene’s Otezla Witnessed Solid Growth in 1Q18.NEWS3: Biogen’s Key Partnerships: Eisai, Pfizer, AbbVie, and Ionis.NEWS4: Why Did Biogen and AbbVie Recall Zinbryta?.NEWS5: AbbVie to Present at the UBS Global Healthcare Conference.NEWS6: How Analysts View Allergan after Its 1Q18 Earnings.
2018-05-09: NEWS1: How Did Regeneron Pharmaceuticals Perform in 1Q18?.NEWS2: 3 Top Biotech Stocks to Buy in May.
2018-05-10: NEWS1: 3 Dividend Stocks for In-the-Know Investors.NEWS2: Exploring AbbVie’s Cash Flows.NEWS3: What’s AbbVie’s Business Strategy for 2018?.NEWS4: Analyzing AbbVie’s Financial Performance.NEWS5: Exploring AbbVie’s Research Programs in Oncology and Neurology.NEWS6: Exploring the Key Aspects of AbbVie’s Research Pipeline.NEWS7: Analyzing AbbVie’s Humira, Imbruvica, and HCV Products.NEWS8: Analyzing AbbVie’s Product Performance.NEWS9: How Much Upside Do Analysts Expect from AbbVie?.NEWS10: Analysts’ Recommendations for Regeneron Pharmaceuticals in May.
2018-05-11: NEWS1: Why Do 113 Top-Rated Funds Own Shares In This Breakout Cloud Stock?.NEWS2: 3 Dividend Stocks for In-the-Know Investors.NEWS3: 3 Dividend Stocks for In-the-Know Investors.
2018-05-14: NEWS1: The Trump Plan To Reduce Prescription Drug Prices Will Have A Major Impact.NEWS2: Vanguard Growth ETF Experiences Big Inflow.NEWS3: Vanguard Growth ETF Experiences Big Inflow.

Answer: Decrease